Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy

American Journal of Chinese Medicine

Volumn 42, Issue 4, 2014, Pages 785-797

  Chen, Huai Min ^a,b   Liou, Shu Fen ^c   Hsu, Jong Hau ^a,b   Chen, Tsan Ju ^a   Cheng, Tsung Lin ^a   Chiu, Chaw Chi ^a,b   Yeh, Jwu Lai ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Baicalein; Cardiac Hypertrophy; High Mobility Group Box 1; Lipopolysaccharide; Matrix Metalloproteinases; Reactive Oxygen Species

Indexed keywords

BAICALEIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; HERBACEOUS AGENT; LIPOPOLYSACCHARIDE; PROTECTIVE AGENT; ANTIOXIDANT; FLAVANONE DERIVATIVE; HBP1 PROTEIN, RAT; NOS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DOWN REGULATION; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; NEWBORN; NONHUMAN; PLANT ROOT; PROTEIN EXPRESSION; RAT; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IN VITRO STUDY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEIN TRANSPORT; ANIMAL; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHYTOTHERAPY; PROTEIN SYNTHESIS; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CARDIOMEGALY; CELLS, CULTURED; DOWN-REGULATION; FLAVANONES; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PROTEIN BIOSYNTHESIS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SCUTELLARIA BAICALENSIS;

EID: 84904301803     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X14500505     Document Type: Article

References (28)

1. Abarbanell, A.M., J.A. Hartley, J.L. Herrmann, B.R. Weil, Y. Wang, M.C. Manukyan, J.A. Poynter and D.R. Meldrum. Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury. Surgery 149: 329-335, 2011.
2. Chang, W.T., J. Li, M.S. Vanden Hoek, X. Zhu, C.Q. Li, H.H. Huang, C.W. Hsu, Q. Zhong, S.J. Chen, T.L. Vanden Hoek and Z.H. Shao. Baicalein preconditioning protects cardiomyocytes from ischemia-reperfusion injury via mitochondrial oxidant signaling. Am. J. Chin. Med. 41: 315-331, 2013.
3. Chen, Y.C., S.C. Shen, L.G. Chen, T.J. Lee and L.L. Yang. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem. Pharmacol. 61: 1417-1427, 2001.
4. Cheng, P.Y., Y.M. Lee, Y.S. Wu, T.W. Chang, J.S. Jin and M.H. Yen. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem. Pharmacol. 73: 793-804, 2007.
5. Ding, H.S. and J. Yang. High mobility group box-1 and cardiovascular diseases. Saudi Med. J. 31: 486-489, 2010.
6. Ducharme, A., S. Frantz, M. Aikawa, E. Rabkin, M. Lindsey, L.E. Rohde, F.J. Schoen, R.A. Kelly, Z. Werb, P. Libby and R.T. Lee. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106: 55-62, 2000.
7. Heymans, S., A. Luttun, D. Nuyensm, G. Theilmeier, E. Creemers, L. Moons, G.D. Dyspersin, J.P. Cleutjens, M. Shipley, A. Angellilo, M. Levi, A. Baker, E. Keshet, F. Lupu, J.M. Herbert, J.F. Smits, S.D. Shapiro, M. Baes, M. Borgers, D. Collen, M.J. Daemen and P. Carmeliet. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5: 1135-1142, 1999.
8. Hsu, J.H., J.R. Wu, S.F. Liou, H.M. Chen, Z.K. Dai, I.J. Chen and J.L. Yeh. Labedipinedilol-A prevents lysophosphatidylcholine-induced vascular smooth muscle cell death through reducing reactive oxygen species production and anti-apoptosis. Atherosclerosis 217: 379-386, 2011.
9. Khadour, F.H., D. Panas, P. Ferdinandy, C. Schulze, T. Csont, M.M. Lalu, S.M. Wildhirt and R. Schulz. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am. J. Physiol. Heart Circ. Physiol. 283: H1108-H1115, 2002.
10. Lancel, S., O. Joulin, R. Favory, J.F. Goossens, J. Kluza, C. Chopin, P. Formstecher, P. Marchetti and R. Neviere. Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111: 2596-2604, 2005.
11. Lee, Y.M., P.Y. Cheng, L.S. Chim, C.W. Kung, S.M. Ka, M.T. Chung and J.R. Sheu. Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1 and suppression of inflammatory responses. J. Ethnopharmacol. 135: 179-185, 2011.
12. Li, W., J. Li, M. Ashok, R. Wu, D. Chen, L. Yang, H. Yang, K.J. Tracey, P. Wang, A.E. Sama and H. Wang. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J. Immunol. 178: 3856-3864, 2007.
13. Li, X.Q., W. Cao, T. Li, A.G. Zeng, L.L. Hao, X.N. Zhang and Q.B. Mei, Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int. Immunopharmacol. 9: 1032-1041, 2009.
14. Oh, Y.C., W.K. Cho, Y.H. Jeong, G.Y. Im, K.J. Lee, H.J. Yang and J.Y. Ma. Anti-inflammatory effect of Sosihotang via inhibition of nuclear factor-KB and mitogen-activated protein kinases signaling pathways in lipopolysaccharide- stimulated RAW 264.7 macrophage cells. Food Chem. Toxicol. 53: 343-351, 2013.
15. Oozawa, S. Effects of HMGB1 on ischemia-reperfusion injury in the rat heart. Circ. J. 72: 1178-1184, 2008.
16. Peng, T., X. Lu, M. Lei and Q. Feng. Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J. Biol. Chem. 278: 8099-8105, 2003.
17. Peng, Z.Y., H.Z. Wang, M.J. Carter, M.V. Dileo, J.V. Bishop, F.H. Zhou, X.Y. Wen, K. Singbartl, W.J. Federspiel, G. Clermont and J.A. Kellum. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 81: 363-369, 2012.
18. Peterson, J.T., H. Li, L. Dillon and J.W. Bryant. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infracted rat. Cardiovasc. Res. 46: 307-315, 2000.
19. Qi, Z., F. Yin, L. Lu, L. Shen, S. Qi, L. Lan, L. Luo and Z. Yin. Baicalein reduces lipopolysac-charide-induced inflammation via suppressing JAK/STATs activation and ROS production. Inflamm. Res. 62: 845-855, 2013.
20. Qin, S., H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C.J. Czura, J.M. Huston, E. Miller, X. Lin, B. Sherry, A. Kumar, G. Larosa, W. Newman, K.J. Tracey and H. Yang. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203: 1637-1642, 2006.
21. Qiu, J., J. Xu, Y. Zheng, Y. Wei, X. Zhu, E.H. Lo, M.A. Moskowitz and J.R. Sims. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 41: 2077-2082, 2010.
22. Shao, Z.H., C.Q. Li, T.L. Vanden, Hoek, L.B. Becker, P.T. Schumacker, J.A. Wu, A.S. Attele and C.S. Yuan. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J. Mol. Cell. Cardiol. 31: 1885-1895, 1999.
23. Shao, Z.H., T.L. Vanden, Hoek, Y. Qin, L.B. Becker, P.T. Schumacker, C.Q. Li, L. Dey, E. Barth, H. Halpern, G.M. Rosen and C.S. Yuan. Baicalein attenuates oxidant stress in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 282: H999-H1006, 2002.
24. Wang, H., M.F. Ward and A.E. Sama. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32: 348-357, 2009.
25. Wright, G., I.S. Singh, J.D. Hasday, I.K. Farrance, G. Hall, A.S. Cross and T.B. Rogers. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression. Am. J. Physiol. Heart Circ. Physiol. 282: H872-H879, 2002.
26. Xu, H., Z. Su, J. Wu, M. Yang, J.M. Penninger, C.M. Martin, P.R. Kvietys and T. Rui. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J. Immunol. 184: 1492-1498, 2010.
27. Yeh, J.L., J.H. Hsu, P.J. Wu, S.F. Liou, C.P. Liu, I.J. Chen, B.N. Wu, Z.K. Dai and J.R. Wu. KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways. Br. J. Pharmacol. 159: 1151-1160, 2010.
28. Yeh, J.L., J.H. Hsu, J.C. Liang, I.J. Chen and S.F. Liou. Lercanidipine and labedipinedilol-A attenuate lipopolysaccharide/interferon-7-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities. Atherosclerosis 226: 364-372, 2013.